Conducted from 18 July to 26 July 2016
Shilpa Medicare announced that the Company had an audit conducted by the United States Food & Drug Administration (USFDA) at the SEZ Formulations facility situated at Jadcherla, near Hyderabad, from 18 July 2016 to 26 July 2016.The Company has received without 483 for the above mentioned facility.
Powered by Capital Market - Live News
